Speakers
Senior Director, Benefit-Risk Assessment, Global R&D Epidemiology, Janssen Research & Development, LLC
Bennett Levitan, MD-PhD is Senior Director, Global R&D Epidemiology at Janssen R&D. He introduced state of the art patient-focused benefit-risk assessment to Janssen and his team has led numerous clinical teams in benefit-risk assessments and patient preference studies. He co-led...
Read More →
Benefit-Risk Management Scientist, Global Patient Safety, Eli Lilly and Company, United States
Kristin Bullok, PhD, is a research scientist in benefit-risk management at Eli Lilly and Company, Global Patient Safety. Since joining Lilly, she has years of combined experience in conducting structured benefit-risk assessments, consulting on patient preference trade-off studies...
Read More →
Deputy Director, Office of Biostatistics and Epidemiology, CBER, FDA
Telba is Deputy Director of the Office of Biostatistics and Epidemiology at CBER. She joined FDA to implement the use of Bayesian statistics for the regulation of medical devices and led the Decision Analysis initiative including Bayesian statistics, benefit-risk determinations, and...
Read More →
PhD Researcher, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven
Rosanne Janssens is a PhD researcher working on the PREFER project at the KU Leuven in Belgium, in the Regulatory Sciences & Pharmaco-Economics research unit. Her research aims at identifying multi-stakeholder challenges and solutions towards designing, conducting and using patient...
Read More →
Thursday June 18, 2020 5:00pm - 6:00pm EDT
TBD
Virtual Event Horsham, PA 19044